Sartorius Stedim Biotech SA
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€851.00 | Nzfdw | Xdttqrryl |
Sartorius Stedim Reset in 2023 Tougher Than Anticipated
Business Strategy and Outlook
Sartorius Stedim Biotech, the bioprocess subsidiary of Sartorius AG, is a leading provider of single-use biopharmaceutical fermentation and fluid management solutions. It offers services ranging from early-stage consultancy to commercial-scale equipment. After an initial period of consultation and customer-partnered engineering work, Sartorius does custom installation of biomanufacturing systems for its customers, consisting of bioreactors, fermenters, and cell analysis systems. This equipment has high disposable consumable requirements because customized filters are often used for disinfection due to the sensitivity of biochemical processes. The company’s proven expertise in single-use technology and the regulation-validated nature of biomanufacturing gives Sartorius an attractive razor/razor blade model.